Vonafexor
Vonafexor (EYP001) is a potent and selective agonist of the farnesoid X receptor (FXR/NR1H4) . It demonstrates anti-hepatitis B virus (HBV) activity and has been investigated in both in vitro assays and in vivo preclinical models for chronic liver diseases, including HBV infection.
Product Specifications
CAS Number
1192171-69-9
Product Name Alternative
Vonafexor, EYP 001, EYP001, EYP-001, FXR, Inhibitor, HBV, Hepatitis B virus, inhibit, NR1H4, PLX007, PLX-007, PLX 007, pxl007
Field of Research
Infectious Disease & Virology, Metabolism Research
Purity
98.74% (May vary between batches)
Solubility
DMSO:22.5 mg/mL (45.94 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.08 mM)
Smiles
OC (=O) c1cc2c (Cl) c (ccc2o1) N1CCN (CC1) S (=O) (=O) c1c (Cl) cccc1Cl
Molecular Formula
C19H15Cl3N2O5S
Molecular Weight
489.76
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
127683-AP 100 µL
GYG1 (Glycogenin 1, Glycogenin-1, GN-1, GN1, GYG) (AP) discontinued
Sign In for Pricing
View Details